Part,  Chapter, Paragraph

1   II,     5.  5.  3|     2005; Dowding et al, 2006; Lindgren et al, 2005; von Campenhausen
2   II,     5.  5.  3|       1998; LePen et al, 1999; Lindgren et al, 2005; McCrone et
3   II,     5.  5.  3| Pharmacoeconomics 16(1):59-69.~Lindgren P, von Campenhausen S, Spottke
4   II,     5.  6.  1|       categories (Jacobson and Lindgren, 1996) and the most common
5   II,     5.  6.  3|       of illness (Jacobson and Lindgren, 1996).~ ~Economic impact~ ~
6   II,     5.  6.  6|        1456-61~Jacobson L. and Lindgren B (1996): Vad kostar sjukdomarna? (